Platelet-Targeted Gene Therapy for Hemophilia A with Inhibitor History | NEJM
Factor VIII gene was introduced into hematopoietic stem cells in men with hemophilia. The annualized bleeding rate went from 10 to 0. No worrisome gene integrations were seen.